Andrew R. Waldeck, Ph.D. joined Parker Highlander after completing a graduate program in chemistry at The University of Texas at Austin. Prior to his graduate studies, Andrew received a B.S. in Chemistry as well as a B.S. in Mathematics from The University of Vermont. During his graduate program, Andrew worked in the area of developing transition-metal catalyzed reactions as well as their application in the context of the total synthesis of biologically active natural products. Since joining Parker Highlander, Andrew has focused on conducting patentability searches as well as the drafting and prosecution of patents related to various areas of chemistry including small molecule therapeutics, chemical synthesis, anti-body drug conjugates, and polymers.
Prior to joining Parker Highlander, Andrew received his Ph.D. from The University of Texas at Austin in Chemistry. His research focused on synthetic organic chemistry, specifically transition-metal catalysis and its application to the total syntheses of Cryptocaryol A and Cyanolide A. During his graduate program, Andrew co-authored three scientific manuscripts on his research.